EULAR/ERA 2019 vs KDIGO 2021 for Lupus Nephritis Management EULAR/ERA 2019 vs KDIGO 2021 for Lupus Nephritis Management
This article highlights the differences between these two proposed guidelines for lupus nephritis management.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2023 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
Experts Share Experience Prescribing Voclosporin, Belimumab Experts Share Experience Prescribing Voclosporin, Belimumab
While some rheumatologists expressed a treatment preference, patients with lupus nephritis tend to do well with both medications; cost and awareness are issues that hold back prescribing in some areas.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 9, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
Two Biomarkers Identify High-Risk Lupus Nephritis Two Biomarkers Identify High-Risk Lupus Nephritis
Two biomarkers, elastase-DNA and HMGB1-DNA, correlate with poor outcomes in patients with lupus nephritis.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 14, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Does snake envenoming cause chronic kidney disease? A cohort study in rural Sri Lanka - Waiddyanatha S, Silva A, Weerakoon K, Siribaddana S, Isbister GK.
BACKGROUND: There is limited information on the risk of chronic kidney disease (CKD) following snakebite and its relationship with chronic interstitial nephritis in agricultural communities (CINAC). We aimed to investigate CKD in patients with a confirmed ... (Source: SafetyLit)
Source: SafetyLit - November 30, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Monthly News Roundup - July 2022
GSK’s Benlysta Is First Approved Treatment for Pediatric Lupus Nephritis
Benlysta (belimumab) is now approved for children 5 to 17 years of age who have lupus nephritis and are receiving standard therapy. Benlysta is not recommended in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2022 Category: Pharmaceuticals Source Type: news
FDA Approves Belimumab for Children With Lupus Nephritis FDA Approves Belimumab for Children With Lupus Nephritis
Children with lupus-related kidney damage can now receive the B-cell reducing therapy that adults with lupus nephritis have been receiving for the past 2 years.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 28, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news
GSK Announces US FDA Approval of Benlysta (belimumab) for Pediatric Patients with Active Lupus Nephritis
Benlysta is now the first and only biologic approved for adults and children who have lupus or lupus nephritis
London UK 27 July 2022 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 27, 2022 Category: Drugs & Pharmacology Source Type: news
First Drug OK'd for Lupus Nephritis in Kids
(MedPage Today) -- The FDA expanded the approval of belimumab (Benlysta) to include treatment of pediatric patients with active lupus nephritis, drugmaker GSK announced on Wednesday.
Already approved in adults with lupus nephritis, belimumab's... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - July 27, 2022 Category: Pediatrics Source Type: news
Mobile Health Apps for SLE and Lupus Nephritis Mobile Health Apps for SLE and Lupus Nephritis
There are numerous mobile health apps specifically intended for patients with SLE and lupus nephritis, but how useful are they?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Early lupus patient data sends Kezar Life Sciences' stock soaring after-hours
A Peninsula drug developer's stock ballooned more than 100% in after-hours trading Monday after it disclosed early data from a midstage clinical trial of a drug designed to treat the autoimmune kidney disease lupus nephritis.
Kezar Life Sciences Inc. (NASDAQ: KZR) said lupus nephritis patients responded well — including some with a complete response — after 24 weeks of treatment with the company's drug zetomipzomib.
Lupus nephritis is a type of kidney disease caused by systemic lupus, where… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 28, 2022 Category: Biotechnology Authors: Ron Leuty Source Type: news
Continuing, Stopping Immunosuppression Tested in Lupus Nephritis Continuing, Stopping Immunosuppression Tested in Lupus Nephritis
Risk of renal relapse and SLE flares was greater in patients with lupus nephritis who discontinued rather than continued immunosuppressive therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news
What Is the Most Common Type of Lupus Nephritis?
Title: What Is the Most Common Type of Lupus Nephritis?Category: Diseases and ConditionsCreated: 6/7/2022 12:00:00 AMLast Editorial Review: 6/7/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 7, 2022 Category: Rheumatology Source Type: news
What Are the 6 Types of Lupus Nephritis?
Title: What Are the 6 Types of Lupus Nephritis?Category: Diseases and ConditionsCreated: 6/7/2022 12:00:00 AMLast Editorial Review: 6/7/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 7, 2022 Category: Rheumatology Source Type: news
Tacrolimus Measures Up in Lupus Nephritis Trial
(MedPage Today) -- In a phase III trial, oral tacrolimus (Prograf) proved non-inferior to intravenous cyclophosphamide for treating lupus nephritis, researchers said.
Among 158 patients randomized to tacrolimus, 83.0% achieved complete or partial... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 30, 2022 Category: Rheumatology Source Type: news
What Are the Symptoms for Lupus Nephritis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 25, 2022 Category: General Medicine Source Type: news
